Clinical Trials Browser

Phase 2 × vorolanib × 90 days × Clear all

NCT07386158 2026-02-04

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Phase 2 Recruiting

Carcinoma, Renal Cell